BE
Bonness Enterprises Portfolio holdings
AUM
$305M
1-Year Return
20.16%
This Quarter Return
+7.31%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$125M
AUM Growth
+$14M
(+13%)
Cap. Flow
+$5.97M
Cap. Flow
% of AUM
4.77%
Top 10 Holdings %
Top 10 Hldgs %
52.54%
Holding
47
New
4
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.07M |
| 2 |
Oracle
ORCL
|
+$1.82M |
| 3 |
Comcast
CMCSA
|
+$1.37M |
| 4 |
Goldman Sachs
GS
|
+$988K |
| 5 |
ISP.CL
ING Groep NV
ISP.CL
|
+$200K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 26.59% |
| 2 | Financials | 25.3% |
| 3 | Technology | 20.4% |
| 4 | Industrials | 8.73% |
| 5 | Materials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$145B
| $23.9M | 19.1% |
610,608
| – | – |
|
2
Stryker
SYK
$148B
| $9.97M | 7.96% |
75,700
| – | – |
|
3
Johnson & Johnson
JNJ
$427B
| $5.11M | 4.08% |
41,038
| – | – |
|
4
GE Aerospace
GE
$299B
| $4.9M | 3.91% |
34,320
| – | – |
|
|
DD
5
DELISTED
Du Pont De Nemours E I
DD
| $4.84M | 3.86% |
60,200
| – | – |
|
6
Microsoft
MSFT
$3.72T
| $3.86M | 3.08% |
58,600
| – | – |
|
7
Unilever
UL
$155B
| $3.55M | 2.83% |
71,940
| – | – |
|
8
Intel
INTC
$116B
| $3.27M | 2.61% |
90,750
| – | – |
|
9
IBM
IBM
$240B
| $3.25M | 2.59% |
19,523
| – | – |
|
10
Merck
MRK
$212B
| $3.14M | 2.51% |
51,771
| – | – |
|
11
Bristol-Myers Squibb
BMY
$97.1B
| $2.94M | 2.35% |
54,100
| – | – |
|
12
Cisco
CSCO
$270B
| $2.72M | 2.17% |
80,400
| – | – |
|
13
Nucor
NUE
$33.1B
| $2.71M | 2.16% |
45,350
| – | – |
|
14
Pfizer
PFE
$141B
| $2.69M | 2.15% |
82,853
| – | – |
|
15
Emerson Electric
EMR
$76.9B
| $2.66M | 2.13% |
44,500
| – | – |
|
16
AbbVie
ABBV
$389B
| $2.45M | 1.96% |
37,600
| – | – |
|
|
17
Berkshire Hathaway Class B
BRK.B
$1.07T
| $2.29M | 1.83% |
13,750
+12,400
| +919% | +$2.07M |
|
18
Applied Materials
AMAT
$136B
| $2.22M | 1.77% |
57,000
| – | – |
|
19
Apple
AAPL
$3.41T
| $2.12M | 1.69% |
58,940
| – | – |
|
20
Marsh & McLennan
MMC
$99B
| $1.98M | 1.58% |
26,800
| – | – |
|
21
Thermo Fisher Scientific
TMO
$185B
| $1.92M | 1.53% |
12,500
| – | – |
|
|
T
22
DELISTED
A T & T CORP (NEW)
T
| $1.86M | 1.49% |
44,800
| – | – |
|
23
Verizon
VZ
$185B
| $1.85M | 1.47% |
37,887
| – | – |
|
|
24
Oracle
ORCL
$875B
| $1.82M | 1.45% |
+40,700
| New | +$1.82M |
|
25
Exxon Mobil
XOM
$480B
| $1.74M | 1.39% |
21,239
| – | – |
|